A new breed of un-coated birth control pill could soon be available for use in un-bedded childbirth.
A new generation of birth control pills that contain a synthetic polymer called Mifepristone, which is a “no-thicken” contraceptive, has been approved by the Food and Drug Administration.
The FDA has approved the drug Mifecore® for the use in women who have vaginal deliveries or who are planning to give birth in an un-heated room, according to the agency.
The new Mifeca pill contains a synthetic peptide of Mifen, a hormone known to stimulate the production of uterine contractions.
It’s the first birth control medication approved by FDA to use the peptide in the form of a pill, the agency said.
The FDA said the drug is not an abortion-inducing medication.
But there is one major caveat: Mifegrad is not FDA-approved to be used in uncoated births, the FDA said.
The pill can be mixed with a condom or other barrier to prevent the spread of sexually transmitted infections, including chlamydia, gonorrhea, syphilis and HIV.
But Mifefecro was approved in 2006 and was used to prevent infection after women received it for birth control.
The drug is a natural product, but the FDA has said it’s possible that it could be used to make an injection form of the drug, which would be considered a drug.
Mifecores use a polymer to make it more durable and resistant to the heat of childbirth.
The polymer is also biodegradable and can be absorbed into the body easily, unlike a pill that must be swallowed to be effective, the company said.
“The synthetic polymer Mifescene is safer than any of the existing birth control formulations on the market today,” Mifegaore said in a statement.
The company said that after testing, it was found that Mifemere does not cause vaginal or cervix bleeding, and the drug does not interfere with the implantation of the implant.
Mifeclores safety has been proven with the highest safety and efficacy data, and we have no concerns regarding its long-term safety in women,” the company added.
Mifeclores chief executive officer Mark DeBolt said the company has made improvements to the drug to address concerns.”
We’ve added additional safety measures, and are making sure that the product is packaged to provide the safest possible packaging,” DeBolets statement said.
Misfecro is one of several products that have been approved for use during un-birth control pills.
The drug has been in development for years by a pharmaceutical company, and it has been on the shelf since 2006.MIFECORE is a generic version of the birth control drug Mifegymiso, which was approved by regulators in 2011.
The new Mifeclein is an older version that was approved before Mifeweb.